3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
17
Neoplasm Metastasis
6
Ovarian Neoplasms
5
Endometrial Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Recurrence
2
Pancreatic Neoplasms
2
Neoplasms
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Liposarcoma
2
Glioma
2
Carcinoma, Renal Cell
2
von Hippel-Lindau Disease
1
Xanthogranuloma, Juvenile
1
Wilms Tumor
1
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Unilateral Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Interventions
Carboplatin
5
Radiotherapy
4
Radiation
3
Radiotherapy, Conformal
2
Platinum
2
Pemetrexed
2
Paclitaxel
2
Magnetic Resonance Spectroscopy
2
Immunoglobulin G
2
Disulfides
2
Cisplatin
2
Bevacizumab
2
1,2-diaminocyclohexaneplatinum II citrate
2
veliparib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
methoxyamine
1
lazertinib
1
durvalumab
1
capmatinib
1
Taxes
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Nivolumab
1
Metformin
1
Ipilimumab
1
Granulocyte Colony-Stimulating Factor
1
Gefitinib
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma of Lung
×
palbociclib
×
30 days
×
Clear all
No trials found.